Skip to main content
. 2014 Jan 11;10(2):165–172. doi: 10.1007/s13181-013-0374-z

Table 2.

Examples of elements to assure safe use

Element Drugs Requirement (examples)
Documentation of safe use Alvimopan (Entereg) Dispensed only at hospitals that perform bowel resections, no more than 15 doses per patient
Isotretinoin (Accutane (off market) and generic) Negative pregnancy test, two documented forms of contraception (iPLEDGE)
Lenalidomide (Revlimid) and all thalidomide analogs Negative pregnancy tests
Vigabatrin (Sabril) Baseline ophthalmologic assessment within 4 weeks then every 3 months after
Prescriber training and/or certification Buprenorphine/naloxone (Suboxone) Complete course and certification
Fentanyl transmucosal (Actiq, Fentora, and several others) Pharmacy check prescriber certification with a sponsor database
Erythropoiesis-stimulating agents (ESA): Aranesp (darbepoetin alfa); Epogen and Procrit (epoetin alfa) Provider and hospital designee must complete training (APPRISE Oncology Program)
Safety monitoring Olanzapine long-acting injection (Zyprexa Relprevv)
Clozapine (Clozaril)
Continuous observation for 3 h post-injection (olanzapine)
Complete blood count (clozapine)
Registries Isotretinoin (generic only)
Vigabatrin (Sabril)
iPLEDGE program
SHARE program
Restricted distribution Oxybate (Xyrem)
Vigabatrin (Sabril)
Distribution from single national pharmacy (Xyrem)